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OL-032 Antimicrobial susceptibility of Staphylococcus
aureus isolated from children with impetigo in
China from 2003 to 2007 shows community
associated MRSA to be uncommon and
heterogenous
Lin Ma*,1, Ying Liu1, Fanrong Kong2, Xia Zhang1,
Mitchell Brown2, Yonghong Yang3. 1Department of Dermatology,
Beijing Children’s Hospital, Capital Medical University, Beijing,
China; 2Centre for Infectious Diseases and Microbiology,
Institute of Clinical Pathology and Medical Research (ICPMR),
Westmead, New South Wales, Australia; 3Beijing Pediatric
Research Institute, Beijing Children’s Hospital, Capital Medical
University, Beijing, China
Objectives: To investigate the antimicrobial susceptibility of
Staphylococcus aureus (S. aureus) causing impetigo in children
in China from 2003 to 2007 and further characterized isolates of
community associated methicillin-resistant Staphylococcus au-
reus (CA-MRSA).
Methods: 984 S. aureus isolates were examined for antimicrobial
susceptibility to 11 antimicrobials using agar dilution method.
CA-MRSA isolates were analyzed for Panton Valentine Leuko-
cidin (pvl) genes, and staphylococcal cassette chromosome mec
(SCCmec) typing was performed.
Results: The largest proportion (94.5%) of strains were resistant
to penicillin, followed by erythromycin (86.2%) and clindamycin
(69.6%). In total 772/984 (78.5%) S. aureus were multiresistant.
The incidence of CA-MRSA was 1.1%, which with a high rate of
resistance to clindamycin (90.9%) and tetracycline (72.7%), but
all of them were susceptible to ciproﬂoxacin. The susceptibil-
ity proﬁles of MRSA to other antimicrobial agents were similar
to those of methicillin-sensitive Staphylococcus aureus (MSSA).
None of the S. aureus strains were resistant to vancomycin and
fusidic acid, moreover only one strain was resistant to mupirocin.
Typing of the SCCmec showed that 54.5% were type IV, 18.2%
were type V and 9.1% were type VI. All the pvl- positive CA-MRSA
carried SCCmec IV.
Conclusion: CA-MRSA is still relatively uncommon and heteroge-
nous in children in China. Penicillin and erythromycin are no
longer appropriate agents. Effective antibiotic agents for pa-
tients with impetigo are mupirocin and fusidic acid.
OL-033 Detection of ESBLs and AmpC enzyme produced
by Enterobacter cloacae
Rong Wang*, Xue Li, Shangwei Wu, Ping He, Bumei Zhang,
Yunde Liu. Department of Laboratory Science, Tianjin Medical
University, Tianjin, China
Objective: To establishment and evaluated a new method named
ﬁve-disk agar diffusion method which can test ESBLs and AmpC of
Enterobacter cloacae (E. cloacae) at the same time. The regular
clinical methods, four-disk test which detect the AmpC and the
double-disk synergy test which detect the ESBLs were compared.
Methods: Strains of E. cloacae were isolated and identiﬁed by
automatic microbe system VITEK; ESBLs and AmpC enzyme were
determined by ﬁve-disk agar diffusion method, four-disk test and
double-disk synergy test, respectively.
Results: In 33 strains of E. cloacae, there were 12 (36.4%) strains
produced ESBLs, 3 (9.1%) strains produced AmpC, and 7 (21.2%)
strains produced both ESBLs and AmpC enzymes by ﬁve-disk
test. There were 9 (27.3%) strains produced AmpC enzyme by
four-disk test. Besides, there were 20 (60.6%) strains produced
ESBLs by double-disk synergy test. Compared with four-disk test
and double-disk synergy test, the coincidence rates of ﬁve-disk
synchronous test were 90% and 95% respectively. The positive
rates of ESBLs by ﬁve-disk test and double-disk test have no
signiﬁcance (P>0.05). And the positive rates of AmpC enzyme
by ﬁve-disk test and four-disk test also have no signiﬁcance
(P>0.05).
Conclusion: Five-disk test is simple, rapid and suitable for assay
and differentiation of producing AmpC or ESBLs among E. cloa-
cae. Because allows for testing of AmpC and ESBLs Enzyms on a
single plate, it is also more cost-effective.
OL-034 In vitro activity of daptomycin against
Staphylococcus epidermidis, Staphylococcus
aureus, Enterococcus faecium and Enterococcus
faecalis isolates at a general hospital
Asimoula Koteli *,1, Elli Antypa2, Georgios Voloudakis3,
Eleni Antoniadou4, Eleni Antoniadou2. 1Microbiology
Laboratory, "G. Gennimatas" General Hospital of Thessaloniki;
2Intensive Care Unit, "G. Gennimatas" General Hospital of
Thessaloniki; 3Medical School, University of Crete, Heraklion;
4Intensive Care Unit "G. Gennimatas" General Hospital of
Thessaloniki
Background: Daptomycin is a new lipopeptide bactericidal an-
timicrobial agent and introduces a new mechanism of action
against Gram-positive bacteria.
Objectives: To determine the in vitro activitie of daptomycin
against clinical isolates of S. aureus, S. epidermidis, E. faecium
and E. ‘faecalis from inpatients hospitalized in the intensive care
unit of our hospital.
Methods: 235 non-duplicate isolates were chosen for suscep-
tibilty testing in 2008. All patients had the clinical signs and
symptoms of sepsis. This collective comprised 55 isolates of
S. aureus including 28.4% MRSA, 104 of S. epidermidis includ-
ing 42.4% MRSE, 48 isolates of E. faecalis and 27 isolates of
E. faecium. Identiﬁcation and routine antibiograms of the iso-
lates were carried out using the Vitek 2 automated system
(BioMerieux®, Marcy I’Etolie, France). Minimum inhibitory con-
centrations (MICs) of daptomycin was determinated by the agar
dilution method according to Clinical Laboratory Standards Insti-
tute (CLSI) guidelines.
Results: All strains tested of S. aureus and S. epidermidis were
susceptible to daptomycin (MICs ≤ 1 μg/mL) as well as all strains
of E. faecium and E. faecalis (MICs ≤ 4 μg/mL). At established
CLSI breakpoints for vancomycin (4 μg/mL) 100% respectively,
of the all strains isolates was susceptible. At established CLSI
breakpoints for tigecycline (1 μg/mL), 98% of the S. aureus, 99%
of the S. epidermidis and 98% of the E. faecium and E. faecalis
were susceptible. MICs were ranging between 0.03–1 for S. au-
reus, 0.01–1 for S. epidermidis, 0.25–4 for E. faecalis and 0.5–4
for E. faecium, respectively.
Conclusions: The excellent in vitro bactericidal activity of dap-
tomycin presents the potential role of treatment of severe
infections due to these bacteria.
OL-035 A novel sequence-based coa genotyping method
to discriminate nosocomial methicillin resistant
Staphylococcus aureus isolates
Qingtian Li *,1, Yongzhang Zhu1, Ke Dong1, Chang Liu1,
Yuhua Zhou1, Yuxing Ni 2, Xiaokui Guo1. 1Department of Medical
Microbiology and Parasitology, Institutes of Medical Sciences,
Shanghai Jiao Tong University School of Medicine, Shanghai,
China; 2Department of Clinical Microbiology, Ruijin Hospital,
Shanghai Jiao Tong University School of Medicine, Shanghai,
China
Background: To evaluate a novel methicillin resistant Staphylo-
coccus aureus genotyping method based on coagulase (coa) gene
sequence.
Methods: Ninety nosocomial MRSA strains isolated from a Chi-
nese university hospital were studied with pvl, SCCmec, spa,
MLST, a novel sequence-based coa typing methods and antibiotic
resistance features.
Results: The prevalent strains were MLST type ST239, ST641 or
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spa type t030, t037 and t067. All MRSA isolates were divided to
11 types and about 20 subtypes with coa typing method here.
The discriminate power of this coa typing method was better
than MLST or spa method.
Conclusion: It demonstrated that this sequence-based coa typing
method was a simple, rapid and effective technique applica-
ble for outbreak or local nosocomial MRSA investigations in the
future.
OL-036 Detection Streptococcus pneumoniae and
identiﬁcation of serotype in cerebral spinal ﬂuid
of childhood bacterial meningitis in China
Gang Liu*,1, Erqing Zhang1, Fanrong Kong2, Heying Chen1,
Gilbert Lyn2, Shaoying Li 1. 1Beijing Children’s Hospital Capital
Univeristy of Medical Sciences, Beijing, China; 2CIDM, ICPMR,
Westmead Hospital Sydney, Australia
Objective: We aimed to a) apply PCR for identiﬁcation of S.
Pneumoniae pneumolysin from cerebral spinal ﬂuid samples of
patients with bacterial meningitis; b) apply nested PCR for
detection of serotype (serogroups) of S pneumonia cpsA-cpsB
combined with sequencing and serotype (group) speciﬁc PCR.
Methods: From January 2006 to December 2008, a total number
of 111 CSF samples of cases strictly met bacterial meningitis
diagnosis criteria were investigated.
Results: Combining positive ﬁnding by all PCRs and culture, the
positive ratio of S. pneumoniaemeningitis was 14.4% in this study.
The serotype was identiﬁed in 9 cases. The distribution was two
serotype 14, two serotype 10A, and one for each serotype 2, 5,
19F, 9N and 23 F separately. It was different with the carriage
studies in China and others with respiratory infection studies.
Conclusions: Serotype study including more bacterial meningitis
cases should be included to obtain a more complete description
of invasive S. pneumonia serotype distribution.
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OL-037 Cross-drug resistance of harboring drug resistant
HIV-1 subtypes B’ strains isolated from Chinese
Center Regional former donor blood patients
experienced HAART treatment
Liying Ma*, Jianghong Huang, Hui Xing, Yiming Shao. Chinese
Center for Disease Control and Prevention
This study analysed the genetic and phenotypic cross drug re-
sistance of harboring resistant viruses from therapy failure AIDS
patients in order to better design anti-HIV-1 regimens for future
treatment of HIV/AIDS patients in China.
65 AIDS patients (49 for D4T/DDI/NVP treatment; 16 for AZT/
DDI/NVP treatment) were recruited and the drug resistance was
analysed using plasma RNA extract,RT-PCR and sequence. HIV
viruses were further isolated from the patients’ PBMC and used
for phenotypic drug resistance by an in vitro susceptibility drug
test.
All the patients were infected by HIV-1B’ subtype and harbored
drug resistance to HIV-1 nucleoside reverse transcriptase (RT)
inhibitors, in which 98% is NVP, 51% is AZT, 60% is D4T, 57% is DDI.
In these HIV-1 viruses harboring resistant strains, there are 100%
cross drug resistance to EFV, 92% to DLV, 77% to TDF, 42% to 3TC,
42% to FTC, and 84% to ABC in these therapy regimen without
ABC, 3TC, FTC, TDF, EFV and DLV. Phenotypic drug resistance
showed that the accordance rate between genotypic drug resis-
tance and phenotypic drug resistance in high and intermediate
drug resistance of 3TC, FTC, EFV and ABC is 72%, 78%, 94% and
89% respectively.
There is cross-drug resistance to HIV-1 nucleoside reverse
transcriptase (RT) inhibitors of Chinese AIDS Patients harboring
resistant strains especially EFV and then ABC, FTC and 3TC. This
information will help to rationally design more efﬁcient anti-HIV-
1 regimens for future treatment of HIV/AIDS patients in China.
OL-038 NRTIs’ effects on the quantity of mitochondrial
DNA and HR II in HIV/AIDS patients
Yasong Wu*, Xinyue Chen, Ying Shi, Hao Wu, Dexi Chen, Yu Sun.
STD/AIDS Research Center, Beijing Youan Hospital, Capital
Medical University
Aim: To know NRTIs’ effects on the sequences of hyper variable
region (HR) of mitochondria and the quantity of mitochondrial
DNA (mtDNA).
Methods: 32 HIV/AIDS patients who were receiving ART for more
than 3 years in which 17 had lipodystrophy had been studied.
PBMC were collected at baseline, 6-month, and 2-year after ART.
Total DNA was extracted from PBMCs. MtDNA were examined us-
ing real time PCR. About 700bp fragment which contains HR II of
these individuals PBMCs were ampliﬁed by standard PCR. Alter-
ations were determined by DNA sequencing assay and comparing
with the revised Cambridge Reference Sequence.
Results: mtDNA’s quantity decreased at 6-mouth and 2-year of
ART compare with that of basement. 6 new mutations appeared
in 5 individuals with lipodystrophy at 2-year of ART compared
with basement.
Conclusions: NRTIs could reduce mtDNA’s quantity of PBMC and
might induce mutation. More comprehensive study should be
developed.
OL-039 Initial viral loads and CD4 counts in a cohort of
adolescents presenting with HIV infection
Alicia K. Rapson1, Daniel H. Conway1,2, Roberta Laguerre1,2,
Janet Chen1,2, Jill A. Foster*,1,2. 1St. Christopher’s Hospital for
Children; 2Drexel University College of Medicine
Background: Little data exists about adolescents who acquire
HIV behaviorally and present with CD4 counts meeting US guide-
lines for HAART initiation.
Methods: Retrospective record review was performed record-
ing initial CD4 counts, viral loads for new adolescent patients.
Threshold for medication initiation was 350 cells/μl or less.
Results: 52 records were reviewed. Nearly 1/3 (31%) met criteria
for therapy, with 33% of patients 18 to 21 versus 24% of those less
than 18 years of age meeting criteria. 38% of males met criteria
vs. 23% of females. Average viral load of those under 18 was
46,183 vs. 72,902 for those over 18.
Fig. 1. Percentage of patients with CD4 counts below 350.
Conclusions: Almost a third of all adolescents and nearly a quar-
ter of those under 18 met criteria for HAART initiation at ﬁrst
visit. Surprisingly, these young, presumably newly infected indi-
viduals meet criteria for anti-retroviral therapy early in disease.
Efforts to identify HIV-infected adolescents must be intensiﬁed
at all ages
